| LDR | 02219nam a22003611a 4500 | ||
| 001 | 000241994 | ||
| 003 | MiAaHDL | ||
| 005 | 20250105000000.0 | ||
| 006 | m d | ||
| 007 | cr bn ---auaua | ||
| 008 | 880718s1981 dcua b 101 0 eng | ||
| 010 | ⊔ | ⊔ | ‡a 80070561 |
| 020 | ⊔ | ⊔ | ‡a091733034X ‡q(pbk.) |
| 035 | ⊔ | ⊔ | ‡a(MiU)990002419940106381 |
| 035 | ⊔ | ⊔ | ‡asdr-miu.990002419940106381 |
| 035 | ⊔ | ⊔ | ‡z(MiU)MIU01000000000000000241994-goog |
| 035 | ⊔ | ⊔ | ‡a(OCoLC)7976209 |
| 035 | ⊔ | ⊔ | ‡a(CaOTULAS)160400758 |
| 035 | ⊔ | ⊔ | ‡a(RLIN)MIUG84-B19063 |
| 035 | ⊔ | ⊔ | ‡z(MiU)Aleph000241994 |
| 040 | ⊔ | ⊔ | ‡aDGPO/DLC ‡dCStRLIN ‡dUtOrBLW |
| 050 | 0 | 4 | ‡aRS201.C64 ‡bC66 |
| 082 | 0 | ⊔ | ‡a615/.191 ‡219 |
| 245 | 0 | 0 | ‡aControlled-release pharmaceuticals / ‡cedited by John Urquhart. |
| 260 | ⊔ | ⊔ | ‡aWashington, D.C. : ‡bAmerican Pharmaceutical Association, Academy of Pharmaceutical Sciences, Pharmacology and Toxicology Section, ‡cc1981. |
| 300 | ⊔ | ⊔ | ‡axi, 145 p. : ‡bill. ; ‡c23 cm |
| 336 | ⊔ | ⊔ | ‡atext ‡btxt ‡2rdacontent |
| 337 | ⊔ | ⊔ | ‡aunmediated ‡bn ‡2rdamedia |
| 338 | ⊔ | ⊔ | ‡avolume ‡bnc ‡2rdacarrier |
| 500 | ⊔ | ⊔ | ‡a"Based on a symposium sponsored by the APS Section on Pharmacology and Toxicology at the 27th national meeting of the Academy of Pharmaceutical Sciences, Kansas City, Missouri, November 1979."--T.p. verso. |
| 504 | ⊔ | ⊔ | ‡aIncludes bilbiographical references and index. |
| 505 | 0 | ⊔ | ‡aIntroduction -- Performance requirements for controlled-release dosage forms : therapeutic and pharmacological perspectives / John Urquhart -- Clinical limitations of controlled-release dosage forms / L.F. Prescott -- Controlled-release dosage form design / Felix Theeuwes and William Bayne -- Pharmacokinetic requirements for controlled-release dosage forms / J.D. Rogers and K.C. Kwan -- The effect of the therapeutic regimen on patient compliance and the possible influence of controlled-release dosage forms / R.B. Haynes. |
| 538 | ⊔ | ⊔ | ‡aMode of access: Internet. |
| 650 | ⊔ | 0 | ‡aDrugs ‡xControlled release ‡vCongresses. |
| 700 | 1 | ⊔ | ‡aUrquhart, John, ‡d1934- ‡0http://id.loc.gov/authorities/names/n81066219 ‡1http://id.loc.gov/rwo/agents/n81066219 |
| 710 | 2 | ⊔ | ‡aAcademy of Pharmaceutical Sciences. ‡bPharmacology and Toxicology Section. ‡0http://id.loc.gov/authorities/names/n81065611 ‡1http://id.loc.gov/rwo/agents/n81065611 |
| 899 | ⊔ | ⊔ | ‡a39015006003548 |
| CID | ⊔ | ⊔ | ‡a000241994 |
| DAT | 0 | ⊔ | ‡a20241217194530.0 ‡b20250105000000.0 |
| DAT | 1 | ⊔ | ‡a20250107000637.0 ‡b2025-01-07T17:36:43Z |
| DAT | 2 | ⊔ | ‡a2023-06-24T17:30:02Z |
| CAT | ⊔ | ⊔ | ‡aSDR-MIU ‡cmiu ‡dALMA ‡lprepare.pl-004-009 |
| FMT | ⊔ | ⊔ | ‡aBK |
| HOL | ⊔ | ⊔ | ‡0sdr-miu.990002419940106381 ‡aMiU ‡bSDR ‡cMIU ‡f000241994 ‡pmdp.39015006003548 ‡sMIU ‡1990002419940106381 |
| 974 | ⊔ | ⊔ | ‡bMIU ‡cMIU ‡d20250107 ‡sgoogle ‡umdp.39015006003548 ‡y1981 ‡ric ‡qbib ‡tUS bib date1 >= 1930 |